Patents Represented by Attorney, Agent or Law Firm Scott D. Miller
  • Patent number: 6734284
    Abstract: The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: May 11, 2004
    Assignee: NsGene A/S
    Inventors: Teit E. Johansen, Nikolaj Blom, Claus Hansen
  • Patent number: 6593133
    Abstract: The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: July 15, 2003
    Assignee: NsGENE A/S
    Inventors: Teit E. Johansen, Nikolaj Blom, Claus Hansen
  • Patent number: 6555674
    Abstract: The JeT promoter is a recombinant promoter with transcriptional activity comparable to a number of strong mammalian promoters. The promoter consists of five key elements: (1) a TATA box; (2) a transcription initiation site (Inr); (3) a CAT consensus sequence in conjunction with (4) a CArG element and finally, (5) four Sp1 transcription binding sites (GGGCGG) arranged in two tandems.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: April 29, 2003
    Assignee: NsGene A/S
    Inventor: Jens Tornøe
  • Patent number: 6384188
    Abstract: Substance which bind with high affinity to endotoxin (lipopolysaccharide [LPS]), and which are useful for the prevention or treatment of, for example, Gram-negative and Gram-positive bacterial sepsis, and for the treatment of bacterial and fungal infections as well as for neutralizing effects associated with heparin. The substances are LPS-binding peptides comprising an LPS-binding domain. DNA sequences encoding peptides, recombinant microorganisms containing the DNA, pharmaceutical compositions containing the peptides of the invention, and diagnostic kits. Methods for the detection and removal of bacterial LPS from solutions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 7, 2002
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Adolf Hoess, Robert C. Liddington, George R. Siber
  • Patent number: 6294353
    Abstract: The present invention relates to a method for targeted assembly of distinct active peptide or protein domains into a single complex and to such complexes. The invention relates particularly to the fusion of peptide or protein domains to complementary association domains which are derived from a single tertiary or quaternary structure by segmentation. The association domains are designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: September 25, 2001
    Assignee: MorphoSys AG
    Inventors: Peter Pack, Andrei Lupas